Leverage Analysis Stories

Powell Industries, a leader in the Electrical Equipment & Parts industry, has been demonstrating a strong financial performance, even amidst a modest market downturn. With a total revenue of 532.6M, an income before tax of 9.8M, and a solid net tangible assets of 296.2M, the company's robust financial health is evident. From a leverage perspective, Powell's prudent management of capital is noteworthy, with capital expenditures at a minimal 2.5M and deferred long-term liabilities at a manageable 7.7M.

Powell Industries currently has $2.32 million in liabilities, with a Debt to Equity (D/E) ratio of 0.01. This may suggest that Powell Industries is not fully leveraging its borrowing potential. The asset utilization indicator refers to the revenue generated for every dollar of assets reported by a company.

The company in question, Symbotic, maintains a current ratio of 1.14. This indicates a potential difficulty in meeting its financial obligations when they become due. Debt can serve as a temporary aid for Symbotic, until the point where it struggles to pay it off, either through raising new capital or generating free cash flow.

Evelo Biosciences currently has liabilities amounting to 51.14 million, with a Debt to Equity (D/E) ratio of 1.55. This ratio is roughly average when compared to similar companies. A useful method to evaluate Evelo's asset utilization is by examining the profit generated for each dollar of reported assets.

Vyne Therapeutics, a prominent player in the Biotechnology industry, has seen a significant surge in its stock price, defying the modest market downturn. The stock has seen a 13.59% price percent change, a substantial increase that signals potential for considerable returns. However, it's important to note that Vyne's financial health presents some concerns.

Vyne Therapeutics, a notable player in the Biotechnology industry, has been a topic of interest for investors on the NASDAQ exchange. The company, with a total of 3.2M common stock shares outstanding, has shown some intriguing financial figures. With a total stockholder equity of 31.2M and other stockholder equity amounting to a staggering 692.3M, Vyne Therapeutics seems to have a solid financial foundation.

The company currently holds 3.08 million in liabilities, with a Debt to Equity (D/E) ratio of 0.04. This may suggest that American Superconductor is not leveraging borrowing sufficiently. Our trading advice tool can cross-verify the current analyst consensus on American Superconductor and analyze the company's potential to grow in the present economic cycle.

Rigorous look on American

American Superconductor (AMSC) presents an interesting case for investors looking at leverage opportunities.

Tupperware Brands (TUP), a key player in the Household Goods industry, has shown significant financial leverage in its recent financial reports. The company's Net Invested Capital stands at a substantial $705.4M, indicating a significant amount of capital invested in the business. However, Tupperware's financial health is somewhat concerning, with Non-Current Liabilities Totaling $811.6M and a Net Debt of $595.3M.

Investors in Yellow Corp (USA Stocks: YELL) may be looking at a potentially profitable September, given the company's current financial standing. With a mean deviation of 13.42, the company's stock price has shown a relatively stable performance, which could be a positive sign for potential investors. Yellow Corp's financial health is further evidenced by its substantial end period cash flow of 239M, providing the company with a solid financial cushion.

Despite the anticipated increase in debt in September, Trxade Group (NASDAQ: MEDS), a prominent player in the Healthcare sector and specifically in Pharmaceutical Retailers industry, presents a potential upside for investors. As of August 2, 2023, the company boasts a total stockholder equity of $763.1K and a total revenue of $11.4M. While its total current liabilities stand at $2.1M, the company maintains a cash reserve of $1.1M.